Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.46
Delayed Data
As of 3:59pm ET
 -0.02 / -1.35%
Today’s Change
1.02
Today|||52-Week Range
2.60
-4.58%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close1.48
Today’s open1.47
Day’s range1.46 - 1.55
Volume521,452
Average volume (3 months)1,294,149
Market cap$164.7M
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-42.59%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book11.47

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc+0.22+2.66%
CNATConatus Pharmaceutic...+0.08+1.53%
SBBPStrongbridge Biophar...+0.05+1.11%
VRNAVerona Pharma PLC+2.08+15.38%
Data as of 3:59pm ET, 05/22/2017

Financials

Next reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts